Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.92
+0.58 (2.12%)
At close: Oct 8, 2025, 4:00 PM EDT
28.06
+0.14 (0.50%)
After-hours: Oct 8, 2025, 6:15 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $10.86 billion as of October 8, 2025. Its market cap has decreased by -56.98% in one year.
Market Cap
10.86B
Enterprise Value
4.10B
1-Year Change
-56.98%
Ranking
Category
Stock Price
$27.92
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $10.86B, an increase of 77.55%. That is a compound annual growth rate of 8.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 10.64B | -33.52% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |